JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

Home・Akciju saraksts・NeoGenomics Inc

NeoGenomics Inc

Slēgts

8.99 -4.87

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.99

Max

9.65

Galvenie mērījumi
By Trading Economics
Ienākumi	17M -9.9M
Pārdošana	2.4M 190M
Peļņas marža	-5.196
Darbinieki	2,500
EBITDA	15M 5.3M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+58.26% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 28. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-352M 1.1B
Iepriekšējā atvēršanas cena	13.86
Iepriekšējā slēgšanas cena	8.99

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

7.7 / 10.27 Atbalsts un pretestība

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 4. maijs 18:18 UTC

Tirgus saruna

Bitcoin Pushes Over $80k as Oil-BTC Relationship Steps Aside -- Market Talk

2026. g. 4. maijs 14:38 UTC

Tirgus saruna

Bitcoin Stuck Between Narratives -- Market Talk

2026. g. 4. maijs 14:21 UTC

Tirgus saruna

Bitcoin Below $80k Resistance -- Market Talk

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

2026. g. 1. maijs 17:37 UTC

Tirgus saruna

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

2026. g. 1. maijs 16:38 UTC

Tirgus saruna

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

2026. g. 1. maijs 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 1. maijs 15:43 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 1. maijs 15:43 UTC

Tirgus saruna

Correlation Between Bitcoin and Equities Seen Loosening -- Market Talk

2026. g. 1. maijs 15:43 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 1. maijs 11:40 UTC

Tirgus saruna

Bitcoin Rises as U.S. Stock Futures Point to Further Gains -- Market Talk

2026. g. 1. maijs 07:09 UTC

Tirgus saruna

Peļņas

Bitcoin Rises After Gains on Wall Street -- Market Talk

2026. g. 30. apr. 18:00 UTC

Tirgus saruna

Cryptocurrency Rebounds After Fed Holds Rates Steady -- Market Talk

2026. g. 30. apr. 13:47 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 30. apr. 13:47 UTC

Tirgus saruna

Bitcoin Rises But Iran War Uncertainty Keeps Gains Limited -- Market Talk

2026. g. 30. apr. 07:02 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 30. apr. 07:02 UTC

Tirgus saruna

Peļņas

Global Energy Roundup: Market Talk

2026. g. 30. apr. 07:02 UTC

Tirgus saruna

Peļņas

Bitcoin Recovers Slightly as Trades Weigh Tech Earnings, Iran War News -- Market Talk

2026. g. 29. apr. 18:15 UTC

Tirgus saruna

Cryptocurrency Down Following Fed Decision -- Market Talk

2026. g. 29. apr. 17:25 UTC

Peļņas

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

2026. g. 29. apr. 13:58 UTC

Tirgus saruna

Cryptocurrencies Turn Higher as Market Awaits Fed -- Market Talk

2026. g. 29. apr. 11:18 UTC

Tirgus saruna

Bitcoin Rises Modestly as U.S. Stock Futures Rise -- Market Talk

2026. g. 29. apr. 09:32 UTC

Peļņas

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

2026. g. 29. apr. 07:22 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Energy Roundup: Market Talk

2026. g. 29. apr. 07:22 UTC

Tirgus saruna

Galvenie ziņu notikumi

Bitcoin Edges Higher But Iran War Uncertainties Limit Gains -- Market Talk

2026. g. 28. apr. 22:51 UTC

Peļņas

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

2026. g. 28. apr. 20:51 UTC

Peļņas

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

2026. g. 28. apr. 20:24 UTC

Peļņas

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

2026. g. 28. apr. 17:24 UTC

Tirgus saruna

Bitcoin Stabilizes Around $76k After ETF Inflow Streak Ends -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

58.26% augšup

Prognoze 12 mēnešiem

Vidējais 14.94 USD 58.26%

Augstākais 25 USD

Zemākais 11 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 12 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.